These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11166518

  • 1. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY, Lee MA, Jayathilake K.
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [Abstract] [Full Text] [Related]

  • 2. Multihormonal responses to apomorphine in mental illness.
    Mokrani MC, Duval F, Crocq MA, Bailey PE, Macher JP.
    Psychoneuroendocrinology; 1995 Mar; 20(4):365-75. PubMed ID: 8532820
    [Abstract] [Full Text] [Related]

  • 3. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP.
    Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F, Bellodi L, Perna G, Arancio C, Bertani A.
    Biol Psychiatry; 1997 Nov 15; 42(10):889-97. PubMed ID: 9359974
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
    Monreal JA, Duval F, Mokrani MC, Fattah S, Palao D.
    J Psychiatr Res; 2019 May 15; 112():18-22. PubMed ID: 30836201
    [Abstract] [Full Text] [Related]

  • 8. Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects.
    Lal S, Nair NP, Isaac I, Guyda H, Quirion R.
    Clin Invest Med; 1988 Jun 15; 11(3):218-23. PubMed ID: 3402107
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients.
    Müller-Spahn F, Modell S, Ackenheil M, Brachner A, Kurtz G.
    J Psychiatr Res; 1998 Jun 15; 32(5):265-71. PubMed ID: 9789204
    [Abstract] [Full Text] [Related]

  • 12. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S, Nair NP, Thavundayil JX, Tawar V, Quirion R, Guyda H.
    J Neural Transm Gen Sect; 1991 Jun 15; 85(2):157-64. PubMed ID: 1930878
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal instability of hormone responses in schizophrenia.
    Cleghorn JM, Brown GM, Brown PJ, Kaplan RD, Mitton J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1983 Jun 15; 7(4-6):545-9. PubMed ID: 6686692
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY, Kolakowska T, Fang VS, Fogg L, Robertson A, Lewine R, Strahilevitz M, Busch D.
    Arch Gen Psychiatry; 1984 May 15; 41(5):512-9. PubMed ID: 6721674
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression.
    Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H, Macher JP.
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb 15; 24(2):207-25. PubMed ID: 10800744
    [Abstract] [Full Text] [Related]

  • 16. Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation.
    Brambilla F, Perna G, Bussi R, Bellodi L.
    Psychoneuroendocrinology; 2000 Apr 15; 25(3):301-10. PubMed ID: 10737700
    [Abstract] [Full Text] [Related]

  • 17. Failure of dopaminergic blockade to affect prolactin, growth hormone, and cortisol responses to insulin-induced hypoglycemia in schizophrenics.
    Nathan RS, Sachar EJ, Ostrow L, Asnis GM, Halbreich U, Halpern FS.
    J Clin Endocrinol Metab; 1981 Apr 15; 52(4):807-9. PubMed ID: 7009631
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
    Kolakowska T, Gelder M, Fraser S.
    Br J Psychiatry; 1981 Nov 15; 139():408-12. PubMed ID: 6120733
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of central dopamine receptors in schizophrenia.
    Zemlan FP, Hitzemann RJ, Hirschowitz J, Garver DL.
    Am J Psychiatry; 1985 Nov 15; 142(11):1334-7. PubMed ID: 2865903
    [Abstract] [Full Text] [Related]

  • 20. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P, Nair NP, Lal S, Cervantes P, Guyda H.
    J Neurol Neurosurg Psychiatry; 1976 Sep 15; 39(9):870-6. PubMed ID: 993808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.